Onkologie. 2009:3(1):32-35

Lymphedema - complication of complex breast cancer treatment

MUDr. Martin Wald
Chirurgická klinika UK 2. LF a FN Motol, Praha

Secondary lymphedema, a chronic and progressive disease, is a frequent complication in the complex treatment of breast cancer. The incidence

of lymphedema increases after radiotherapy, and its severity is also dependent on the extent of axillary lymph node dissection.

Lymphedema can affect all soft tissues which are drained by the respective axillary lymph nodes. The primary goal of the therapy

should be detection of the early stages of lymphedema, which are founded foremostly upon personal history, clinical examination, and

lymphoscintigraphy. Standard therapy involves Complex Decongestive Therapy (CDT). Peroral administration of proteases can be used

as a one-drug-only therapy (monotherapy) in the early stages of disease. In later stages complicated by lipohypertrophy and fibrosis,

surgical treatment is the only rational treatment option (liposuction, debulking).

Keywords: secondary lymphedema, incidence, aetiopathogenesis, diagnosis, treatment.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Wald M. Lymphedema - complication of complex breast cancer treatment. Onkologie. 2009;3(1):32-35.
Download citation

References

  1. Bendová M, Benda K. Dotazník k vyhodnocení psychosociální kondice nemocných s lymfedémem. Prakt. flebol. 1999; 6(2): 57-65.
  2. Benda, et al. Lymfedém - komplexní fyzioterapie, lymfodrenáže a doplňující léčebná péče. Národní centrum ošetřovatelství a nelékařských zdravotnických oborů v Brně 2007.
  3. Erickson VS, Pearson ML, Ganz PA, et al. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001; 93(2): 96-111. Go to original source... Go to PubMed...
  4. Hayes, et al. Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function. J Clin Oncol. 2008; 26: 3536-3542. Go to original source... Go to PubMed...
  5. Kiel KD, Rademacker AW. Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology. 1996; 198: 279-283. Go to original source... Go to PubMed...
  6. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88: 608-614. Go to original source...
  7. Del Bianco P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol. 2008; 34(5): 508-513. Go to original source... Go to PubMed...
  8. Aitken RJ, Gaze MN, Rodger A, et al. Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg. 1989; 76: 568-571. Go to original source... Go to PubMed...
  9. Borup ChS, Lundgren E. Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial. Acta Chir Scand. 1989; 155: 515-519. Go to PubMed...
  10. Kissin MW, Querci della Rovere G, Easton D, et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986; 73: 580-584. Go to original source... Go to PubMed...
  11. Petrek JA, Pressman PI, Smith RA. Lymphedema: Current Issues in Research and Management. CA Cancer J Clin. 2000; 50: 292-307. Go to original source... Go to PubMed...
  12. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2003; 1, 55(5): 1209-1215. Go to original source... Go to PubMed...
  13. Mortimer PS, Bates DO, Brassington HD, et al. The prevalence of arm oedema following treatment for breast cancer. Q J Med. 1996; 89: 377-380. Go to original source...
  14. Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer. 1996; 74: 2024-2031. Go to original source... Go to PubMed...
  15. Wald M, Eliska O, Krizova H. Non-extremity lymphedema following axilla dissection and radiotherapy and its relationship to the postmastectomy syndrome. Progress in Lymphology XIX. Lymphology 2004; 37(Suppl.): 1-717.
  16. Wald M, Eliska O, Hoch J, et al. Thoracic- and Abdominal Wall Lymphedema following Surgery of the breast and Axilla. Progress in Lymphology XVIII-2. Lymphology. 2002/3; 35 (Suppl 2): 1-472. Go to PubMed...
  17. Casley-Smith JR. Alterations of untreated lymphedema and its grades over time. Lymphology. 1995; 28: 174-185. Go to PubMed...
  18. Goffman TE, Laronga Ch, Wilson L, et al. Lymphedema of the Arm and Breast in Irradiated Breast Cancer Patients: Risks in an Era of Dramatically Changing Axillary Surgery. Breast J. 2004; 10(5): 405-411. Go to original source... Go to PubMed...
  19. Křížová H, Bechyně M. Přínos lymfoscintigrafie pro diagnostiku lymfedému končetin. Česko-Slovenská pediatrie. 2001; 56(3): 116-119.
  20. Křížová H, Wald M, Barkmanová J. Lymfoscintigrafie u pacientek s nekončetinovým lymfedémem po disekci axily a radioterapii. Klinická Onkologie 2006; 5: 252-255.
  21. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology Executive Committee. Lymphology 1995; 28(3): 113-117. Go to PubMed...
  22. Földi M, Kubik S. Lehrbuch der Lymphologie. Gustav Fischer Verlag, 2. Auflage 1991.
  23. Navrátilová Z. Možnosti farmakologické terapie lymfedému. Remedia. 2003; 13(4).
  24. Wald M, et al. Proteázy v medikamentózní léčbě lymfedému. Praktická flebologie. Suppl. 2000: 11-14.
  25. Wald M, Houdová H, Křížová H, et al. An early (latent) stage of secondary arm lymphedema and its successful treatment with exogenous proteinases. Lymphology 2004; 12: 41.
  26. Wald M. Klasifikace, principy diagnostiky a léčby poruch lymfatické drenáže. In: Štvrtinová V, et al. Choroby ciev, 2008: 921-922.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.